Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245852110249
Publisher
SAGE Publications
Online
2021-07-09
DOI
10.1177/13524585211024997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
- (2020) Jaume Sastre-Garriga et al. Nature Reviews Neurology
- pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis
- (2019) David Kremer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Endogenous Retroviruses in Neurological Diseases
- (2018) Patrick Küry et al. TRENDS IN MOLECULAR MEDICINE
- Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis
- (2018) Victoria Gröger et al. Frontiers in Microbiology
- Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination
- (2018) Peter Göttle et al. GLIA
- Human endogenous retrovirus W env increases nitric oxide production and enhances the migration ability of microglia by regulating the expression of inducible nitric oxide synthase
- (2017) Ran Xiao et al. VIROLOGICA SINICA
- MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment
- (2016) Alexandra Madeira et al. JOURNAL OF NEUROIMMUNOLOGY
- A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis – Rationale and design
- (2016) Francois Curtin et al. Multiple Sclerosis and Related Disorders
- Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis
- (2016) Jack van Horssen et al. Multiple Sclerosis and Related Disorders
- Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis
- (2015) Zheng Liu et al. BRAIN
- The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade
- (2014) David Kremer et al. Multiple Sclerosis Journal
- Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation
- (2013) David Kremer et al. ANNALS OF NEUROLOGY
- Human Endogenous Retrovirus Protein Activates Innate Immunity and Promotes Experimental Allergic Encephalomyelitis in Mice
- (2013) Hervé Perron et al. PLoS One
- Endogenous viruses: insights into viral evolution and impact on host biology
- (2012) Cédric Feschotte et al. NATURE REVIEWS GENETICS
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search